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correlation with survival (8) It is necessary to deﬁne criteria for the best selection
and timing for candidates to lung transplantation.
Registries are an important source of data to investigate clinical and research
questions. This review points out that only in some instances (incidence/survival
analysis) CF Registries are fully able to answer to questions relevant for research.
The main limits concern the analysis of historical cohorts in spite of the large
number of patients registered. It should be demanded to standardize deﬁnitions
of variables, outcome measures and timing of data collection to make results
comparable among Registries.
P5 USE OF NIV IN THE DRAINING THERAPY: CLINICAL CASE
M.A. Ciciretti, L. Ratclif. UOS Cystic Fibrosis Cerignola, Italy
Studies show that the use of NIV, in Cystic Fibrosis, has a positive effect on the
chronic respiratory insufﬁciency in patients affected by advanced pulmonary disease
and/or in waiting lists for a pulmonary transplant, by improving gas transfers and
reducing muscular work.
For this reason we decided to use NIV as support to the draining therapy, focusing
on the following aims:
• improving the compliance of the patient;
• improving the efﬁcacy of the physiotherapeutic treatment;
• estimating the course of the illness.
Clinical case: a male patient, 10 years old, affected by Cystic ﬁbrosis with pancreatic
insufﬁciency and chronically colonized by Pseudomonas aeruginosa. The data in
the table referto the 12 months before NIV and to the NIV* months.
before NIV NIV* months
Physiotherapeutic activity 2−3 sessions per day with PEP-Mask 1 session of NIV and 1 session of
PEP-Mask
Height 130 cm (P) → 132 cm (P) + 132 cm (P) → 137.5 cm (P) +
Weight 28 (P) → 29 Kg (P) + 29.2 Kg (P) → 32 Kg (P) +
Spirometry FEV1 57.7% FEV1 68.4%
Sputum 40 cc with stamps 40cc + ﬂuid without stamps
6 WT 500 mt. with breaks for cough 540 mt. without cough
RX 19 9
Period in bed 52 days No day
Therapy period 56 days (ev) 94 days (os) 16 days (ev) 25 days (os)
Compliance VAS 2 VAS 6
Symptomatology wheezing cough, tiring expectoration, chest
tightness
easy expectoration, no chest tightness.
Also improved PEP session
Tolerance of effort Reduced during physical activity good (gym)
*Resmed pressometric ventilator VPAP III ST-A with nasal mask.
Draining session with 4−5 cycles if C-PAP per 3 days with 7 cm H2O→ use of
Coach 2 (respiratory incentive), 3 fast inspirations and 3 slow ones. → Hufﬁng
Conclusions: the use of the ventilator during a draining therapy produced the
following results:
– Improving the compliance: this was possible because the draining therapy has
been less tiring, faster, with no chest tightness, with a better approach of the
patient to practise the draining session and to require it in case of obstruction.
– Obtaining a better efﬁcacy of the physiotherapeutic treatment: a more ﬂowing
sputum, a relevant reduction of the air instability, a better tolerance of effort.
– Recording positive effects on the course of the illness: spirometric increase,
therapy period reduction, no admission, better saturated-ponderal increase, ra-
diological improvement.
P6 COMPARISON OF HIGH FREQUENCY CHEST WALL OSCILLATION
(HFCWO) AND PEP-MASK IN HOSPITALIZED PATIENTS WITH
CYSTIC FIBROSIS (CF)
F. Alatri, B. Giacomodonato, T. Perelli, L. Graziano, M. Varchetta, G. Cimino,
L. Locorriere, E. Bonci, S. Quattrucci. Centro Fibrosi Cistica Regione Lazio,
Rome, Italy
Background: Reducing bronchial obstruction plays a primary role in the rehabili-
tation of patients with CF. In the last decades treatment has shifted gradually from
passive and tiring techniques to methods that foster self-management of pulmonary
disease, including the use of mechanical tools to loosen secretions. However, the
greater efﬁcacy of such mechanical methods compared to other procedures has not
been demonstrated clearly.
Aim: To compare the efﬁcacy of HFCWO with that of PEP-Mask in the clearance
of bronchial tubes from secretion.
Methods: 10 patients with CF (4 males, average age 21.4±7.5 years) hospitalized
for a relapse of broncho-pulmonary disease. During hospitalization (average length,
6.1±2.7 days) each patient had daily applications of bronchial disobstruction, one
with PEP-Mask and one with HFCWO, each lasting 30 minutes, following standard
procedures. The sequence of the two interventions as changed daily. All patients
were treated with intravenous antibiotics and aerosol bronchodilators. Oxygen was
provided to maintain adequate saturations (SpO2>90%). The following parameters
were evaluated: quantity of ejected humid mucus, SpO2, and heart rate (HR) during
each application of draining physiotherapy, dyspnea and mood assessment using
a visual analogue scale (VAS) at beginning and end of each treatment, FEVI
and WT6min at the start and end of hospitalization, and end-study evaluation
questionnaire. Statistical signiﬁcance was evaluated with the Paired T-Test and
Wilcoxon Signed Rank Test.
Results: Minimum SpO2 during PEP-Mask was 89.3±3.1 vs. 87.2±3.5 during
HFCWO (p< 0.01); average quantity of sputum per treatment was 16±9.6 with
PEP-Mask vs. 10.3±6.5 ml with HFCWO (p< 0.02); HR peak during PEP-
Mask was 116.5±8.8 b/m vs. 120±6.7 b/m for HFCWO (p = 0.08); evaluation
questionnaire showed a perceived greater draining efﬁcacy with PEP-Mask vs.
HFCWO (p< 0.02).
No signiﬁcant differences were identiﬁed for the other parameters.
Conclusions: Compared to HFCWO, treatment with PEP-Mask is associated with
greater draining efﬁcacy, less desaturation, and milder tachycardia in patients with
CF. Studies with larger sample size and longer follow up are warranted.
P7 EFFICACY OF HIGH FREQUENCY CHEST COMPRESSION
(HFCC) IN THE CLEARANCE OF MUCUS IN PATIENTS WITH
CYSTIC FIBROSIS (CF)
M. Ambroni, V. Mazzotti, E. Balestri, S. Dall’Ara, F. Gobbi, F. Lupi, F. Battistini.
Centro Regionale Fibrosi Cistic, Cesena, Italy
Aims: To determinate the efﬁcacy of HFCC (using the VEST) in the clearance
of mucus, by comparing it to the amount of expectorated mucus obtained with
PEP-mask. HFCC is made through a system with an inﬂatable vest, that rapidly
inﬂates and deﬂates to compress and release the chest wall, creating an airﬂow
inside the lungs. This process moves mucus towards the larger airways, where it
can be coughed up and expectorated. PEP-mask is a positive expiratory pressure
generated through a face-mask.
Methods: 10 CF patients (M:W=8:2; mean age=24.3 yrs, range=9−43 yrs),
clinically stable and undergoing their usual therapies (mean FEV1=54.79%,
range=26−93), were randomly recruited. They came twice a week in a 2 weeks
period to perform both VEST and PEP-mask therapy each week (1st day VEST,
2nd day PEP, 3rd day PEP, 4th day VEST).
%SaO2 and cardiac frequency were checked with pulseoximeter every 2min during
each session. We evaluated the emotional state and the fatiguing using VAS scales,
before and after each treatment. The dry expectoration was weighted in laboratory.
HFCC consisted on a VEST treatment of 30min with 3 phases: the ﬁrst consisted
of 7min in a low frequency (8Hz) and pressure (P = 4), the second consisted of
7min at 10Hz and P = 5, and the third of 7min at 15Hz and P = 6. Every phase
was followed by a pause of 3min where they did 3 cough bouts and expectorated.
They did a total of 9 cough bouts followed by expectorations.
PEP-mask consisted of a 30min treatment. Patients did 7min of PEP (with a pause
of 20 sec every 2min) followed by a pause of 3min where they did 3 cough
bouts and expectorated for 3 times. They did a total of 9 cough bouts followed
by expectorations.
Results: See the table.
VEST PEP-mask P value
Sputum gr 34.09±10.28 34.91±9.84 0.483
% SaO2 mean 95.18±1.79 95.49±1.38 0.293
Peak %SaO2 desat 91.90±3.29 91.30±3.05 0.441
% pz VAS amusing 30 10
% pz VAS fatiguing 45 45
Conclusions: VEST is as much effective as PEP-mask technique in clearing sputum
from airways of CF patients. No differences neither in the amount of sputum
expectorated nor in peak SaO2% desaturation were showed. VEST was perceived
as less distressing than PEP-mask, in the same fatiguing condition. So the VEST
may be used as substitute or integrative to PEP, to create an alternative to the classic
chest physical therapy.
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P8 AUTOMATION OF CFTR RE-SEQUENCING: TIME AND COSTS
ANALYSIS
G. Ferraguti1, S. Pierandrei1, S.M. Bruno1, F. Ceci1, A. Di Gioia1, S. Quattrucci2,
R. Strom1, M. Lucarelli1. 1Dept. of Cellular Biotechnologies and Hematology,
2Dept. of Pediatrics, Regional CF Centre, “La Sapienza” University of Rome,
Italy
Among methods for mutational scan of Cystic Fibrosis Transmembrane Conduc-
tance Regulator (CFTR) gene, direct sequencing ensures the highest degree of de-
